Reports for SOLID Drug Development SA
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.Find out more
Economic information
Comprehensive information about the economic situation of a company.Find out more
Payment collection information
Overview of current and past debt enforcement proceedings.Find out more
Company dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.Retrieve company dossier
About SOLID Drug Development SA
- SOLID Drug Development SA from Genève operates in the sector «Research and development» and is active.
- The management of the company SOLID Drug Development SA consists of 2 persons. The foundation of the company took place on 29.03.2010.
- The last commercial register change was made on 06.10.2023. All changes can be viewed under the section «Notifications» and saved as a PDF.
- The company's UID is CHE-115.555.939.
- B29 SA, Blackbear SA, BUILT sa are registered at the same address.
Management (2)
newest board members
Jean-Marc Combette,
Catherine Marcelle Gilberte Deloche de Noyelle-Transon
newest authorized signatories
Jean-Marc Combette,
Catherine Marcelle Gilberte Deloche de Noyelle-Transon
Commercial register information
Entry in the commercial register
29.03.2010
Legal form
Company limited by shares (AG)
Legal headquarters of the company
Genève
Commercial Registry Office
GE
Commercial register number
CH-660.0.863.010-8
UID/VAT
CHE-115.555.939
Sector
Research and development
Purpose (Original language)
Fourniture de tout service technique, scientifique, réglementaire et marketing en matière de recherche, de développement, de production et de commercialisation de médicaments, d'outils de diagnostique et d'accessoires médicaux (cf. statuts pour but complet).
Other company names
Es sind keine früheren oder übersetzten Firmannamen vorhanden.
Would you like to update the company name? Click here.Branches (0)
Ownership structure
Holdings
Newest SOGC notifications: SOLID Drug Development SA
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: HR02-1005855201, Commercial Registry Office Geneva, (660)
SOLID Drug Development SA, à Genève, CHE-115.555.939 (FOSC du 19.12.2013, p. 0/7225832).
Nouvelle adresse:
Rue du Pré-Jérôme 12, 1205 Genève.
Publication number: 5692566, Commercial Registry Office Geneva, (660)
SOLID Drug Development SA, à Genève, CH-660-0863010-8 (FOSC du 06.04.2010, p. 8/5572868).
Nouvelle adresse:
rue John Grasset 8, 1205 Genève.
Publication number: 5572868, Commercial Registry Office Geneva, (660)
SOLID Drug Development SA, à Genève, rue de l'Athénée 42, c/o Catherine Deloche, 1206 Genève, CH-660-0863010-8. Nouvelle société anonyme. Statuts du 24.03.2010.
But:
fourniture de tout service technique, scientifique, réglementaire et marketing en matière de recherche, de développement, de production et de commercialisation de médicaments, d'outils de diagnostique et d'accessoires médicaux (cf. statuts pour but complet).
Capital-actions:
CHF 100'000, entièrement libéré, divisé en 100 actions de CHF 1'000, nominatives, liées selon statuts.
Organe de publication:
Feuille Officielle Suisse du Commerce.
Communication aux actionnaires:
lettre recommandée.
Administration:
Combette Jean-Marc, de France, à Saint-Cergues, F, président, et Deloche Catherine, de et à Genève, tous deux avec signature individuelle. Selon déclaration du conseil d'administration du 24.03.2010, la société n'est pas soumise à un contrôle ordinaire et renonce à un contrôle restreint.
Hit list
Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.